(Q37887798)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663459%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

review article

1 reference

title

Drug safety evaluation of zonisamide for the treatment of epilepsy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663459%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663459%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Gaetano Zaccara

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663459%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Luciana Tramacere

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663459%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

English

0 references

publication date

29 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663459%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Safety

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663459%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663459%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663459%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

623-631

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21663459%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide as adjunctive therapy for refractory partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Introduction to zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Interaction between Ca2+, K+, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

The anticonvulsant zonisamide scavenges free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Clinical pharmacology and therapeutic drug monitoring of zonisamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Pharmacokinetics and drug interactions with zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide: newer antiepileptic agent with multiple mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Clinical pharmacokinetics of new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide concentrations during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Pharmacokinetics of zonisamide in perinatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Central nervous system adverse effects of new antiepileptic drugs. A meta-analysis of placebo-controlled studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide (CI-912) and cognition: results from preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Long-term efficacy and safety of zonisamide monotherapy in epilepsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide-induced mania in an essential tremor patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Neuroleptic malignant syndrome-like state in an epileptic patient with organic brain comorbidity treated with zonisamide and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Idiosyncratic adverse reactions to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide in pediatric epilepsy: review of the Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Rash from antiepileptic drugs: influence by gender, age, and learning disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Practical prescribing and long-term efficacy and safety of zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Toxic epidermal necrolysis due to zonisamide associated with reactivation of human herpesvirus 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Acute kidney injury caused by zonisamide-induced hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Cross-reactivity pattern of rash from current aromatic antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Predicting possible zonisamide hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Mechanistic perspectives on sulfonamide-induced cutaneous drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

The structure and function of carbonic anhydrase isozymes in the respiratory system of vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Carbonic anhydrases: current state of the art, therapeutic applications and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide and renal calculi in patients with epilepsy: how big an issue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Anticonvulsants in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Bone mineral density in subjects using central nervous system-active medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Antiobesity carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Dopamine receptor subtype agonists and feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide: chemistry, mechanism of action, and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide and associated oligohidrosis and hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Oligohydrosis and fever in pediatric patients treated with zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Effects of zonisamide monotherapy in children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Xerosis and pityriasis alba-like changes associated with zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Possible mechanism for zonisamide-induced hyperammonemia in a child with citrullinemia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Reduced anesthetization during the intracarotid amobarbital (Wada) test in patients taking carbonic anhydrase-inhibiting medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

The teratogenic risk of antiepileptic drug polytherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Topiramate and zonisamide prevent paradoxical intoxication induced by carbamazepine and phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Zonisamide for weight loss in obese adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Open-label zonisamide for refractory migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201

Neurological comorbidity and epilepsy: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2011.571201